Qiagen Analyst Ratings
Qiagen Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/17/2023 | 27.78% | JP Morgan | $55 → $50 | Maintains | Overweight |
| 09/26/2023 | 53.34% | Citigroup | $60 → $60 | Reiterates | Buy → Buy |
| 09/12/2023 | 27.78% | Baird | → $50 | Initiates Coverage On | → Outperform |
| 08/09/2023 | 22.67% | UBS | $50 → $48 | Maintains | Neutral |
| 02/09/2023 | 32.89% | UBS | $50 → $52 | Maintains | Neutral |
| 02/09/2023 | 53.34% | Citigroup | $55 → $60 | Maintains | Buy |
| 11/09/2022 | 40.56% | Citigroup | $62 → $55 | Maintains | Buy |
| 12/14/2021 | 53.34% | Wells Fargo | $58 → $60 | Maintains | Equal-Weight |
| 10/14/2021 | — | Redburn Partners | Initiates Coverage On | → Buy | |
| 07/14/2021 | 26.58% | Kepler Cheuvreux | → $49.53 | Downgrades | Buy → Hold |
| 06/03/2021 | 32.89% | Goldman Sachs | → $52 | Initiates Coverage On | → Neutral |
| 10/06/2020 | 50.78% | B of A Securities | → $59 | Upgrades | Neutral → Buy |
| 09/28/2020 | 51.6% | Kepler Cheuvreux | → $59.32 | Upgrades | Hold → Buy |
| 08/26/2020 | 68.67% | Commerzbank | → $66 | Upgrades | Hold → Buy |
| 08/24/2020 | 58.45% | Citigroup | $48 → $62 | Upgrades | Neutral → Buy |
| 08/20/2020 | 53.34% | JP Morgan | → $60 | Reinstates | → Overweight |
| 08/14/2020 | — | Exane BNP Paribas | Upgrades | Neutral → Outperform | |
| 08/14/2020 | 53.34% | Deutsche Bank | $32 → $60 | Upgrades | Hold → Buy |
| 04/02/2020 | 2.22% | Stifel | $33 → $40 | Maintains | Hold |
| 03/06/2020 | 7.33% | CFRA | $38 → $42 | Maintains | Hold |
| 02/06/2020 | -2.89% | CFRA | $40 → $38 | Maintains | Hold |
| 01/10/2020 | -8% | UBS | $39 → $36 | Maintains | Neutral |
| 01/08/2020 | -8% | Wells Fargo | → $36 | Initiates Coverage On | → Equal-Weight |
| 01/07/2020 | -10.55% | Citigroup | → $35 | Initiates Coverage On | → Neutral |
| 12/26/2019 | -28.44% | B of A Securities | → $28 | Reinstates | → Underperform |
| 11/18/2019 | 22.67% | Commerzbank | → $48 | Upgrades | Hold → Buy |
| 11/15/2019 | -15.67% | Stifel | → $33 | Initiates Coverage On | → Hold |
| 11/14/2019 | 2.22% | JP Morgan | $25 → $40 | Upgrades | Underweight → Overweight |
| 10/09/2019 | — | Kepler Cheuvreux | Downgrades | Hold → Reduce | |
| 10/08/2019 | -15.67% | B of A Securities | $40 → $33 | Maintains | Neutral |
| 10/08/2019 | -20.78% | Piper Sandler | $36 → $31 | Maintains | Neutral |
| 10/08/2019 | -36.11% | JP Morgan | $38 → $25 | Downgrades | Neutral → Underweight |
| 07/16/2019 | — | Evercore ISI Group | Downgrades | Outperform → In-Line | |
| 03/15/2019 | 7.33% | UBS | → $42 | Initiates Coverage On | → Neutral |
| 10/31/2018 | 4.78% | Morgan Stanley | $39 → $41 | Maintains | Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 10/17/2023 | 27.78% | 摩根大通 | $55→$50 | 维护 | 超重 |
| 09/26/2023 | 53.34% | 花旗集团 | $60→$60 | 重申 | 购买→购买 |
| 09/12/2023 | 27.78% | 贝尔德 | →$50 | 开始承保 | →跑赢大盘 |
| 08/09/2023 | 22.67% | 瑞银集团 | $50→$48 | 维护 | 中性 |
| 02/09/2023 | 32.89% | 瑞银集团 | $50→$52 | 维护 | 中性 |
| 02/09/2023 | 53.34% | 花旗集团 | $55→$60 | 维护 | 买 |
| 11/09/2022 | 40.56% | 花旗集团 | $62→$55 | 维护 | 买 |
| 2021年12月14日 | 53.34% | 富国银行 | $58→$60 | 维护 | 等重 |
| 10/14/2021 | - | Redburn合作伙伴 | 开始承保 | →购买 | |
| 07/14/2021 | 26.58% | 开普勒盛富银行 | →$49.53 | 评级下调 | 购买→Hold |
| 06/03/2021 | 32.89% | 高盛 | →$52 | 开始承保 | →中性 |
| 10/06/2020 | 50.78% | B of A证券 | →$59 | 升级 | 中性→购买 |
| 09/28/2020 | 51.6% | 开普勒盛富银行 | →$59.32 | 升级 | 持有→购买 |
| 2020/08/26 | 68.67% | 德国商业银行 | →$66 | 升级 | 持有→购买 |
| 08/24/2020 | 58.45% | 花旗集团 | $48→$62 | 升级 | 中性→购买 |
| 08/20/2020 | 53.34% | 摩根大通 | →$60 | 恢复 | →超重 |
| 2020/08/14 | - | 法国巴黎银行 | 升级 | 中性→表现优异 | |
| 2020/08/14 | 53.34% | 德意志银行 | $32→$60 | 升级 | 持有→购买 |
| 04/02/2020 | 2.22% | Stifel | $33→$40 | 维护 | 保持 |
| 03/06/2020 | 7.33% | CFRA | $38→$42 | 维护 | 保持 |
| 02/06/2020 | -2.89% | CFRA | $40→$38 | 维护 | 保持 |
| 2020/10/01 | -8% | 瑞银集团 | $39→$36 | 维护 | 中性 |
| 1/08/2020 | -8% | 富国银行 | →$36 | 开始承保 | →等重 |
| 1/07/2020 | -10.55% | 花旗集团 | →$35 | 开始承保 | →中性 |
| 2019年12月26日 | -28.44% | B of A证券 | →$28 | 恢复 | →表现不佳 |
| 2019年11月18日 | 22.67% | 德国商业银行 | →$48 | 升级 | 持有→购买 |
| 2019年11月15日 | -15.67% | Stifel | →$33 | 开始承保 | →保留 |
| 2019年11月14日 | 2.22% | 摩根大通 | $25→$40 | 升级 | 减持→超重 |
| 2019年10月09日 | - | 开普勒盛富银行 | 评级下调 | 按住→减量 | |
| 2019年10月08日 | -15.67% | B of A证券 | $40→$33 | 维护 | 中性 |
| 2019年10月08日 | -20.78% | 派珀·桑德勒 | $36→$31 | 维护 | 中性 |
| 2019年10月08日 | -36.11% | 摩根大通 | $38→$25 | 评级下调 | 中性→减持 |
| 2019年07月16日 | - | Evercore ISI集团 | 评级下调 | 胜过→同线 | |
| 2019年03月15日 | 7.33% | 瑞银集团 | →$42 | 开始承保 | →中性 |
| 2018年10月31日 | 4.78% | 摩根士丹利 | $39→$41 | 维护 | 超重 |
What is the target price for Qiagen (QGEN)?
奇根(QGEN)的目标价是多少？
The latest price target for Qiagen (NYSE: QGEN) was reported by JP Morgan on October 17, 2023. The analyst firm set a price target for $50.00 expecting QGEN to rise to within 12 months (a possible 27.78% upside). 7 analyst firms have reported ratings in the last year.
JP摩根于2023年10月17日报道了启元(纽约证券交易所代码：QGEN)的最新目标价。这家分析公司将目标价定为50美元，预计QGEN将在12个月内升至(可能上涨27.78%)。去年有7家分析公司公布了评级。
What is the most recent analyst rating for Qiagen (QGEN)?
分析师对QGEN的最新评级是多少？
The latest analyst rating for Qiagen (NYSE: QGEN) was provided by JP Morgan, and Qiagen maintained their overweight rating.
JP摩根对奇根(纽约证券交易所代码：QGEN)的最新分析师评级是由摩根大通提供的，奇根维持其增持评级。
When is the next analyst rating going to be posted or updated for Qiagen (QGEN)?
QGEN的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Qiagen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Qiagen was filed on October 17, 2023 so you should expect the next rating to be made available sometime around October 17, 2024.
分析师在进行了广泛的研究后得出了股票评级，这些研究包括查阅公共财务报表，与启元的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。对Qiagen的上一次评级是在2023年10月17日提交的，所以你应该预计下一次评级将在2024年10月17日左右提供。
Is the Analyst Rating Qiagen (QGEN) correct?
分析师对齐根(QGEN)的评级正确吗？
While ratings are subjective and will change, the latest Qiagen (QGEN) rating was a maintained with a price target of $55.00 to $50.00. The current price Qiagen (QGEN) is trading at is $39.13, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的启元(QGEN)评级维持不变，目标价在55.00美元至50.00美元之间。QGEN目前的交易价格为39.13美元，超出了分析师的预测区间。